Middleway Nutrition
Evidence-based GLP-1 and peptide science.
Clear clinical research, dosing context, safety tradeoffs, and practical guides organized into two focused archives.
Latest Articles
20 articles
GLP-1 Without a Doctor: The Grey Market, China Peptides, and What Actually Works in 2026
There is no legal way to buy GLP-1 medication in the US without a prescription. 'Research peptides' from China are not a loophole — the FDA has been issuing warning letters and seizing shipments through 2026, and contamination, fake dosing, and bacterial growth are routinely documented in seized batches.
GLP-1GLP-1 in Canada 2026: Approvals, CAD Prices, Provincial Coverage, and Telehealth
What's approved, what it costs in CAD, what your province actually covers, the shortage status after 2024, and how Felix, Maple, and other Canadian telehealth options fit. Cross-border buying is illegal — here's what works instead.
GLP-1GLP-1 Pen: How Every Major Injector Works, Doses, Storage, and Troubleshooting
Every GLP-1 brand uses a different pen — some single-dose, some four-dose, some you prime, some you don't. The Zepbound KwikPen (FDA-approved January 2026) now holds a full month in one device.
GLP-1Oral Wegovy vs Injectable Wegovy: Pill Or Weekly Shot?
Oral Wegovy and injectable Wegovy both contain semaglutide, but they differ in dosing routine, absorption, convenience, and practical adherence.
GLP-1GLP-1 for Pre-Diabetes: Trial Data, Type 2 Prevention Rates, and the FDA Gap
GLP-1 medications dramatically reduce progression from prediabetes to type 2 diabetes — up to 94% over 3 years in SURMOUNT-1, 80–84% reverting to normoglycemia in STEP — but no GLP-1 is FDA approved specifically for prediabetes.
GLP-1Is GLP-1 Insulin? No — They Are Two Different Hormones (and Two Different Drug Classes)
GLP-1 is not insulin. Insulin is a 51-amino-acid hormone made in the pancreas whose only job is to lower blood glucose. GLP-1 is a 30-amino-acid gut hormone that triggers your own pancreas to release insulin — and does a half-dozen other things insulin does not. They are commonly confused because both are injected and both are used in type 2 diabetes.
GLP-1GLP-1 and Joint Pain: Why Most People Get Better, and Why a Minority Get Worse
The STEP-9 trial showed semaglutide cut knee osteoarthritis pain by ~42 points on a 100-point scale at 68 weeks. But a small subgroup develops new joint pain on GLP-1s — almost always from rapid muscle loss, dehydration, gout flares, or post-loss biomechanics. Both directions explained.
GLP-1Amylin Agonist Guide: The Next Obesity Drug Pathway To Watch
Amylin agonists are emerging as a major obesity-drug pathway because they may complement GLP-1 appetite and metabolic effects.
GLP-1Cagrilintide Guide: The Amylin Analogue Behind CagriSema
Cagrilintide is an investigational long-acting amylin analogue being studied for obesity and metabolic disease, including in combination with semaglutide.
GLP-1CagriSema Guide: Cagrilintide Plus Semaglutide
CagriSema is Novo Nordisk's investigational fixed-dose combination of cagrilintide and semaglutide for weight management.
GLP-1GLP-1 After 3 Months: The Checkpoint That Decides the Next Year
At the 3-month mark, real-world data shows ~5.9% mean weight loss on semaglutide and 7–10% on tirzepatide. That number determines insurance coverage, dose decisions, and whether to switch drugs.
GLP-1GLP-1 Qualifications: Who Actually Qualifies in 2026 (BMI, Conditions, Age)
FDA approval criteria and insurance prior authorization criteria are not the same thing — and insurance is usually stricter. Here is who qualifies for a GLP-1 in 2026, what counts as a qualifying weight-related condition, and what to do if you don't qualify yet.
GLP-1GLP-1 After Gastric Bypass: Weight Regain, Timing, and Dose Guide
Adding a GLP-1 after gastric bypass or sleeve produces 5–15% additional weight loss in patients who plateaued or regained. Most surgeons wait at least 12 months post-op and prefer injectable over oral semaglutide.
GLP-1GLP-1 Success Stories: 10 Real Composite Patient Outcomes (and What Set the High Responders Apart)
Roughly 25–32% of trial patients on high-dose GLP-1s lose more than 20% of body weight. Real-world results are lower. Here are 10 composite stories showing the full range — from 100+ lb losses to non-responders — and what separates them.
GLP-1Does GLP-1 Help With Inflammation? What the CRP, IL-6, and TNF-α Data Show
GLP-1 medications reliably lower systemic inflammation markers. CRP drops 20–30% on semaglutide and up to 50–65% on tirzepatide. Some of that is weight loss; some is direct anti-inflammatory action via immune-cell GLP-1 receptors.
GLP-1GLP-1 vs Bariatric Surgery: Which Wins for Weight Loss?
Bariatric surgery still produces about twice the weight loss of GLP-1 medications and holds it longer. GLP-1s are easier, reversible, and increasingly used before, after, or instead of surgery.
GLP-1GLP-1 Before Surgery and Colonoscopy: ASA + AGA 2024 Guidelines
The 2023 ASA rule was simple: hold weekly GLP-1s for 7 days, daily ones for 24 hours. The 2024 multisociety update is more nuanced — most patients can continue, with a 24-hour clear liquid diet as the main safeguard.
GLP-1GLP-1 vs Metformin: A Head-to-Head Comparison for Type 2 Diabetes and Weight Loss
Metformin is dirt cheap and still the default first pill for type 2 diabetes. GLP-1s drop A1C harder and produce 3-10x more weight loss — at 100-300x the price. Most patients end up on both, not one or the other.
GLP-1GLP-1 And The Gut Microbiome: What We Know So Far
The GLP-1 and microbiome relationship is likely bidirectional, but probiotic-style claims still outrun the evidence.
GLP-1GLP-1 with B12: Honest Analysis of Compounded Semaglutide + Cyanocobalamin (Marketing vs Evidence)
Compounded semaglutide and tirzepatide are sometimes sold with 1000 mcg of B12 mixed in. The pitch is more energy, less nausea, better metabolism. The evidence is thinner than the marketing suggests — here is what B12 actually does, when it matters, and when it is just a differentiator.